These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7803786)

  • 21. Structure of the Hodgkin's lymphoma-associated human CD30 gene and the influence of a microsatellite region on its expression in CD30(+) cell lines.
    Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Krause H; Pohl T; Stein H
    Biochim Biophys Acta; 2001 Jun; 1519(3):185-91. PubMed ID: 11418184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
    Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
    Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
    Rinaldi I
    Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.
    Renner C; Jung W; Sahin U; Denfeld R; Pohl C; Trümper L; Hartmann F; Diehl V; van Lier R; Pfreundschuh M
    Science; 1994 May; 264(5160):833-5. PubMed ID: 8171337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease.
    da Costa L; Renner C; Hartmann F; Pfreundschuh M
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S33-6. PubMed ID: 10950145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic significance of the CD30 (Ki-1) antigen.
    Pallesen G
    Histopathology; 1990 Apr; 16(4):409-13. PubMed ID: 2163354
    [No Abstract]   [Full Text] [Related]  

  • 27. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
    Romaguera JE; Garcia-Foncillas J; Cabanillas F
    Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of CD137 Immunohistochemical Stain on Paraffin-Embedded Tissue as a Marker to Facilitate Distinction Between Classic Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, and Anaplastic Large Cell Lymphoma.
    Carbone PN; Zhang QY
    Arch Pathol Lab Med; 2019 Mar; 143(3):280-281. PubMed ID: 30816829
    [No Abstract]   [Full Text] [Related]  

  • 29. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
    Savoldo B; Rooney CM; Di Stasi A; Abken H; Hombach A; Foster AE; Zhang L; Heslop HE; Brenner MK; Dotti G
    Blood; 2007 Oct; 110(7):2620-30. PubMed ID: 17507664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice.
    Barth S; Huhn M; Matthey B; Tawadros S; Schnell R; Schinköthe T; Diehl V; Engert A
    Blood; 2000 Jun; 95(12):3909-14. PubMed ID: 10845927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma.
    Xu J; Oki Y; Saksena A; Desai P; Lin P; Tang G; Yin CC; You MJ; Thakral B; Medeiros LJ; Li S
    Hum Pathol; 2017 Feb; 60():160-166. PubMed ID: 27816715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines.
    Heuck F; Ellermann J; Borchmann P; Rothe A; Hansen H; Engert A; von Strandmann EP
    J Immunother; 2004; 27(5):347-53. PubMed ID: 15314543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large Cells With CD30 Expression and Hodgkin-like Features in Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Study of 13 Cases.
    Prieto-Torres L; Manso R; Cieza-Díaz DE; Jo M; Kilany Pérez L; Montenegro-Damaso T; Eraña I; Lorda M; Suarez Massa D; Machan S; Córdoba R; Ara M; Requena L; Rodriguez-Pinilla SM; Piris MA
    Am J Surg Pathol; 2019 Sep; 43(9):1191-1202. PubMed ID: 31145160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimerization of a monoclonal antibody for treating Hodgkin's lymphoma.
    Krauss J; Förster HH; Uchanska-Ziegler B; Ziegler A
    Methods Mol Biol; 2003; 207():63-79. PubMed ID: 12412468
    [No Abstract]   [Full Text] [Related]  

  • 35. Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement.
    Megahed NA; Kohno K; Sakakibara A; Eladl AE; Elsayed AA; Wu CC; Suzuki Y; Takahara T; Kato S; Nakamura S; Satou A; Asano N
    Pathol Int; 2019 Dec; 69(12):697-705. PubMed ID: 31872533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous multifocal CD30+ anaplastic large cell lymphoma.
    Asha LK; Thomas D; Binitha MP; Nandakumar G
    Indian J Dermatol Venereol Leprol; 2006; 72(5):376-8. PubMed ID: 17050936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colonic CD30 positive plasmablastic plasmacytoma masquerading as anaplastic large cell lymphoma.
    Chang ST; Hsieh YC; Kuo CC; Chuang SS
    Pathology; 2018 Oct; 50(6):668-670. PubMed ID: 30098797
    [No Abstract]   [Full Text] [Related]  

  • 38. CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disorders.
    Younes A; Carbone A
    Int J Biol Markers; 1999; 14(3):135-43. PubMed ID: 10569134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: primary CD30 (Ki-1)-positive anaplastic large cell lymphoma of the duodenum.
    Yoshikawa I; Murata I; Tanaka Y; Kanagawa K; Tabaru A; Itoh H; Otsuki M
    Dig Dis Sci; 1996 Dec; 41(12):2343-7. PubMed ID: 9011440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
    Ranuhardy D; Suzanna E; Sari RM; Hadisantoso DW; Andalucia R; Abdillah A
    Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.